Nuvation Bio Inc
Nuvation Bio Inc (NUVB) Option Chain
As of September 23, 2026, Nuvation Bio Inc is trading at $5.73, a +0.35% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 86.4%. IV Rank is 31%.
Read more
Tracking the NUVB option chain helps you see every strike and expiry on Nuvation Bio Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Nuvation Bio Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of NUVB options activity at a glance. Use our scanner to monitor the NUVB option chain in real time and filter for the NUVB options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For NUVB stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the NUVB option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where NUVB stock options are being actively traded and where they are not.
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation; NUV-569, a differentiated oral small molecule selective inhibitor of the Wee1 kinase for DNA damage repair; NUV-1182, an adenosine receptor inhibitor; and drug-drug conjugate (DDC) platform that focuses on targeting an inhibitor of poly ADP ribose polymerase (PARP) to anti-cancer warheads of existing drugs, as well as PARP inhibitor to address ER+ breast and ovarian cancer.
The company was formerly known as RePharmation Inc. and changed its name to Nuvation Bio Inc. in April 2019. Nuvation Bio Inc. was founded in 2018 and is headquartered in New York, New York.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Nuvation Bio Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen NUVB options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of NUVB stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile55.95% Neutral
- Market cap (M$)2,018
- 52 weeks high-41.23%
- 52 weeks low91.64%
- Analyst recommendationStrong Buy
1.17 - Target price$13.10
128.62% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-02
- P/E—
- Future P/E—
- EPS (ttm)-0.44
- EPS growth next 5 years—
As of September 23, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 0.05 | 0 | 0 | -0.08 | 3.23 | 2.00 | 4.30 | 2.50 | -56.22 | — | 0.05 | 0.00 | 0.05 | 0 | 1 | 99.95 |
| 33.21 | 11 | 0 | 0.37 | 0.73 | 0.70 | 1.50 | 5.00 | -12.43 | 0.05 | 0.20 | 0.00 | 0.13 | 1 | 564 | 66.79 |
| 89.10 | 2,875 | 12 | 0.08 | 0.00 | 0.05 | 0.10 | 7.50 | +31.35 | 1.65 | 2.05 | 1.77 | 0.08 | 0 | 39 | 10.90 |
| 99.21 | 62 | 0 | 0.75 | 0.00 | — | 0.75 | 10.00 | +75.13 | 3.30 | 4.50 | 4.27 | -0.37 | 0 | 0 | 0.79 |
| 99.96 | 0 | 0 | 0.75 | 0.00 | — | 0.75 | 12.50 | +118.91 | 5.60 | 7.10 | 6.77 | -0.42 | 0 | 0 | 0.04 |
As of September 23, 2026
Scan the full option chain in one place
Browse the full NUVB option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→